Green, A.R., Powe, D.G., Rakha, E.A., Soria, D., Lemetre, C., Nolan, C.C., Barros, F.F.T., Macmillan, R.D., Garibaldi, J.M., Ball, G.R., and others. (2013) Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. British Journal of Cancer, 109 (7). pp. 1886-1894. ISSN 0007-0920. E-ISSN 1532-1827. (doi:10.1038/bjc.2013.528) (KAR id:98892)
PDF
Publisher pdf
Language: English
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
|
|
Download this file (PDF/1MB) |
|
Request a format suitable for use with assistive technology e.g. a screenreader | |
Official URL: https://doi.org/10.1038/bjc.2013.528 |
Abstract
Background:Breast cancer is a heterogeneous disease characterised by complex molecular alterations underlying the varied behaviour and response to therapy. However, translation of cancer genetic profiling for use in routine clinical practice remains elusive or prohibitively expensive. As an alternative, immunohistochemical analysis applied to routinely processed tissue samples could be used to identify distinct biological classes of breast cancer.Methods:In this study, 1073 archival breast tumours previously assessed for 25 key breast cancer biomarkers using immunohistochemistry and classified using clustering algorithms were further refined using naïve Bayes classification performance. Criteria for class membership were defined using the expression of a reduced panel of 10 proteins able to identify key molecular classes. We examined the association between these breast cancer classes with clinicopathological factors and patient outcome.Results:We confirm patient classification similar to established genotypic biological classes of breast cancer in addition to novel sub-divisions of luminal and basal tumours. Correlations between classes and clinicopathological parameters were in line with expectations and showed highly significant association with patient outcome. Furthermore, our novel biological class stratification provides additional prognostic information to the Nottingham Prognostic Index.Conclusion:This study confirms that distinct molecular phenotypes of breast cancer can be identified using robust and routinely available techniques and both the luminal and basal breast cancer phenotypes are heterogeneous and contain distinct subgroups. © 2013 Cancer Research UK.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.1038/bjc.2013.528 |
Uncontrolled keywords: | breast cancer classification, immunohistochemistry, stratification, Tumour biomarkers |
Subjects: | Q Science |
Divisions: | Divisions > Division of Computing, Engineering and Mathematical Sciences > School of Computing |
Funders: | University of Nottingham (https://ror.org/01ee9ar58) |
Depositing User: | Daniel Soria |
Date Deposited: | 08 Dec 2022 10:01 UTC |
Last Modified: | 05 Nov 2024 13:04 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/98892 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):